Published in Transpl Immunol on November 09, 2010
Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75
A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health (2011) 5.26
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A (2013) 2.99
Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl (2012) 1.98
Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Liver Transpl (2010) 1.59
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng (2006) 1.57
Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation (2009) 1.50
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology (2004) 1.46
Cancer inflammation and inflammatory biomarkers: can neutrophil, lymphocyte, and platelet counts represent the complexity of the immune system? Transpl Int (2014) 1.45
High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14(+)CD16(++) monocytes in patients with inflammatory disorders. Clin Immunol (2012) 1.39
Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol (2008) 1.35
Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology (2012) 1.33
Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut (2011) 1.21
Understanding centenarians' psychosocial dynamics and their contributions to health and quality of life. Curr Gerontol Geriatr Res (2010) 1.19
Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. J Biol Chem (2006) 1.15
Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. J Hepatol (2012) 1.05
Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl (2006) 1.01
Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. Eur J Pharmacol (2011) 1.00
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo. Hepatology (2012) 1.00
Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl (2003) 0.99
Defining early human NK cell developmental stages in primary and secondary lymphoid tissues. PLoS One (2012) 0.98
Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol (2005) 0.97
Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells. Transplantation (2010) 0.96
NK cells can generate from precursors in the adult human liver. Eur J Immunol (2011) 0.94
Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl (2010) 0.93
Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev (2012) 0.93
Characterization of human liver dendritic cells in liver grafts and perfusates. Liver Transpl (2006) 0.92
Human plasmacytoid dendritic cells induce CD8⁺ LAG-3⁺ Foxp3⁺ CTLA-4⁺ regulatory T cells that suppress allo-reactive memory T cells. Eur J Immunol (2011) 0.90
Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection. FEBS Lett (2011) 0.90
Combined antiviral activity of interferon-alpha and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing. J Mol Med (Berl) (2009) 0.88
From research tool to routine test: CD38 monitoring in HIV patients. Cytometry B Clin Cytom (2009) 0.87
Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant (2003) 0.87
mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment. World J Transplant (2013) 0.87
Arterial vascular conduits in adult orthotopic liver transplant recipients. ANZ J Surg (2006) 0.86
Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells. Blood (2013) 0.85
Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. Exp Biol Med (Maywood) (2013) 0.85
Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J Immunol (2007) 0.84
Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol (2002) 0.84
Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transpl (2011) 0.84
Influence of personality and health behaviors on fatigue in late and very late life. J Gerontol B Psychol Sci Soc Sci (2006) 0.84
Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology (2008) 0.83
Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection. Transplantation (2008) 0.83
Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance. Transpl Immunol (2009) 0.82
Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection. Liver Transpl (2002) 0.82
Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns. Transplantation (2003) 0.82
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection. J Infect Dis (2003) 0.82
MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation. J Hepatol (2013) 0.82
Lipidomic profiling of phosphocholine-containing brain lipids in mice with sensorimotor deficits and anxiety-like features after exposure to Gulf War agents. Neuromolecular Med (2012) 0.82
Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients. J Med Virol (2004) 0.81
Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model. J Neurotrauma (2011) 0.81
Proteomic CNS profile of delayed cognitive impairment in mice exposed to Gulf War agents. Neuromolecular Med (2011) 0.81
Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha. Liver Transpl (2010) 0.81
Assessment of the microsurgical skills: 30 minutes versus 2 weeks patency. Microsurgery (2007) 0.80
Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood (2007) 0.80
Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl (2002) 0.80
T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment. Oncoimmunology (2013) 0.80
Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. J Hepatol (2005) 0.80
Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors. Transplantation (2006) 0.80
Role of the hepatic parenchyma in liver transplant tolerance: a paradigm revisited. Dig Dis (2011) 0.80
Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome. Transpl Int (2011) 0.79
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique. FEMS Immunol Med Microbiol (2003) 0.79
Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl (2009) 0.79
Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts. Transplantation (2013) 0.79
Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma. Hum Pathol (2006) 0.79
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. Transplantation (2002) 0.78
Gene array analysis of a rat model of liver transplant tolerance identifies increased complement C3 and the STAT-1/IRF-1 pathway during tolerance induction. Liver Transpl (2006) 0.78
Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transpl (2010) 0.78
Long-lived intragraft donor leukocytes or relocated donor hematopoietic stem/progenitor cells can cause long-term hematopoietic chimerism after liver transplantation. Hepatology (2013) 0.77
Immunomagnetic selection of functional dendritic cells from human lymph nodes. Immunol Lett (2005) 0.77
Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay. PLoS One (2010) 0.76
Expression of common gamma chain signalling cytokines and their receptors distinguishes rejection from tolerance in a rat organ transplant model. Transpl Immunol (2012) 0.76
Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery? Discov Med (2010) 0.76
Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules. Immunology (2003) 0.75
Does the donor mannose-binding lectin genotype really predict the risk of bacterial infections after liver transplantation? Hepatology (2011) 0.75
Reliable and reproducible murine models for commonly used abdominal plastic surgical flaps. J Reconstr Microsurg (2012) 0.75
Strain-specific in vitro cytokine production profiles do not predict rat liver allograft survival. Transpl Int (2005) 0.75
Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation. Transplantation (2015) 0.75
Optimized method for ureteric reconstruction in a mouse kidney transplant model. ANZ J Surg (2013) 0.75
Poor Nutritional Status among Low-Income Older Adults: Examining the Interconnection between Self-Care Capacity, Food Insecurity, and Depression. J Acad Nutr Diet (2018) 0.75
Laparoscopic Tenckhoff catheter insertion: a retrospective study over 6 years. ANZ J Surg (2012) 0.75
Superdocs of the 21st century: can they really fly? ANZ J Surg (2013) 0.75
Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts. Transpl Immunol (2004) 0.75
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation. Pharmacogenet Genomics (2014) 0.75
Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration. Transpl Immunol (2008) 0.75
Basiliximab interferes with the detection of soluble IL-2 receptor by the Immulite Immunoassay system. J Immunol Methods (2003) 0.75